The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 1 , Pages 36-42 , January 2009

Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention

  • Najib Safieddine, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Wei Xu, PhD

      Affiliations

    • Department of Biostatistics, Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Sayed Mohammed Quadri, MD, FRCSC

      Affiliations

    • Division of Thoracic Surgery, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Jennifer J. Knox, MD, FRCP

      Affiliations

    • Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Jennifer Hornby, BSc, CCRP

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Joanne Sulman, MSW

      Affiliations

    • Department of Social Work, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Rebecca Wong, MD, FRCP

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Maha Guindi, MD, FRCP

      Affiliations

    • Department of Pathology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Shaf Keshavjee, MD, MSc, FRCSC, FACS

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Gail Darling, MD, FRCSC, FACS

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationAddress for reprints: Gail Darling, MD, FRCSC, FACS, Toronto General Hospital, Division of Thoracic Surgery, 9N-955, 200 Elizabeth St, Toronto, Ontario M5G 2C4, Canada.

Received 29 March 2007 ,Revised 24 September 2008 ,Accepted 30 September 2008.

References 

  1. Darling G, Eton D, Sulman J, Casson A, Cella D. Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer. 2006;107:854–863
  2. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962–972
  3. Alexiou C, Khan OA, Black E, et al. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Ann Thorac Surg. 2006;82:1073–1077
  4. Fok M, Wong J. Cancer of the oesophagus and gastric cardia. Standard oesophagectomy and anastomotic technique. Ann Chir Gynaecol. 1995;84:179–183
  5. Visbal AL, Allen MS, Miller DL, Deschamps C, Trastek VF, Pairolero PC. Ivor Lewis esophagectomy for esophageal cancer. Ann Thorac Surg. 2001;71:1803–1808
  6. Swanson SJ, Batirel HF, Jalitsch MT, et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymphnode dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg. 2001;72:1918–1924
  7. Swisher SG, Holmes EC, Hunt KK, et al. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg. 1996;131:819–824
  8. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy PJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;33:462–467
  9. Urschel JD, Vasan H, Blewett CJ. A meta analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2002;183:274–279
  10. Malaiserie SC, Untch B, Aranha GV. Neoadjuvant chemoradiation for locally advanced esophageal cancer: experience at a single institution. Arch Surg. 2004;139:532–538
  11. Tamim WZ, Davidson RS, Quinlan RM, et al. Neoadjuvant chemotherapy for esophageal cancer: is it worthwhile?. Arch Surg. 1998;133:722–726
  12. Knox J, Darling G, Guindi M, et al. A phase II study to assess the efficacy of combined preoperative irinotican I/cisplatin (C) chemotherapy and conformal radiotherapy (RT) followed by surgery for potentially resectable esophageal cancer. J Clin Oncol. 2004;22(14S):4063
  13. Blazeby JM, Conroy T, Hammerlid F, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life of patients with oesophageal cancer. Eur J Cancer. 2003;39:1384–1394
  14. Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 2000;88:1781–1787
  15. Viklund P, Wengstrom Y, Rouvelas I, Lindblad M, Lagergren J. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer. 2006;42:1407–1414
  16. Brooks JA, Kesler KA, Johnson CS, Ciatta D, Brown JW. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol. 2002;81:185–194
  17. de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004;22:4202–4208
  18. Viklund P, Lindblad M, Lagergren J. Influence of surgery related factors on quality of life after esophageal or cardia cancer resection. World J Surg. 2005;29:841
  19. Bottomley A, Flechtner H, Efficace F, et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer. 2005;41:1697–1709
  20. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006;93:1084–1090
  21. Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol. 2006;17:827–834
  22. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol. 2004;58:1394–1404

 Read at the Eighty-seventh Annual Meeting of The American Association for Thoracic Surgery, Washington, DC, May 5–9, 2007.

PII: S0022-5223(08)01647-4

doi: 10.1016/j.jtcvs.2008.09.049

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 1 , Pages 36-42 , January 2009

Article Tools

* Image Usage & Resolution